Actively Recruiting

Age: 18Years +
All Genders
NCT07433660

WellSpan-THRIVE Cancer QOL Study

Led by WellSpan Health · Updated on 2026-03-02

1000

Participants Needed

5

Research Sites

304 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.

CONDITIONS

Official Title

WellSpan-THRIVE Cancer QOL Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years and above
  • Primary cancer diagnosis (newly diagnosed within the past 6 months)
  • Able to sign informed consent.
Not Eligible

You will not qualify if you...

  • Patients younger than 18 years
  • Patients with primary non-melanoma skin cancer, neurological malignancies (brain or brain metastases), or primary hematological malignancies
  • Patients with severe cognitive impairment who cannot sign informed consent or complete quality of life questionnaire
  • Patients with life expectancy less than 90 days, as determined by the treating investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

WellSpan Medical Oncology & Hematology

Chambersburg, Pennsylvania, United States, 17201

Actively Recruiting

2

WellSpan Ephrata Cancer Center

Ephrata, Pennsylvania, United States, 17522

Actively Recruiting

3

WellSpan Adams Cancer Center

Gettysburg, Pennsylvania, United States, 17325

Actively Recruiting

4

WellSpan Sechler Family Cancer Center

Lebanon, Pennsylvania, United States, 17042

Actively Recruiting

5

WellSpan York Cancer Center

York, Pennsylvania, United States, 17403

Actively Recruiting

Loading map...

Research Team

J

Joan K Moore, MSN, RN, OCN, CCRP

CONTACT

R

Rahul Kashyap, MBBS, MBA, FCCM

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here